Non-invasive Prenatal Testing (NIPT) Market Key Industry Analysis
The report covers a detailed analysis and forecast for the global non-invasive prenatal testing (nipt) market on a global and regional level from 2021 to 2028. The study offers historical data from 2016 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million). The study comprises a comprehensive view of the market with a review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the non-invasive prenatal testing (nipt) market between 2021 and 2028.
These assessments help users of the report to analyze the non-invasive prenatal testing (nipt) market on the basis of different metrics that includes brand loyalty, switching costs, capital investments, economies of scale, regulatory legislation, current sales networks, production rights and patents, customer preferences, and promotional effects. This categorized data is expected to aid industry stakeholders in decision-making.The study also suggests company penetration plans for new entrants. Furthermore, the non-invasive prenatal testing (nipt) industry study report has listed the main manufacturers and distributors operating in all the major regions. We anticipate that this analysis and data will assist industry players to strengthen their networks of market penetration and expand their geographical breadth as a result of their efforts.
Market Research Store (MRS) published a latest report titled “Non-invasive Prenatal Testing (NIPT) Market research report which is segmented by Products (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), by Applications (Aneuploidy, Microdeletion), by Key Players/Companies (Next Biosciences (Pty) Limited, Illumina Inc., Myriad Genetics Inc., Natera Inc., Laboratory Corporation of America Holdings (LabCorp), Beijing Genomics Institute, Quest Diagnostics, F. Hoffmann-La Roche, LifeCodexx AG, Yourgene Health Plc, PerkinElmer Inc., NIPD Genetics)”. In 2020, the global non-invasive prenatal testing (nipt) market demand was registered at XX (USD Million) and is predicted to reach XX (USD Million) at a CAGR of XX% by 2028.
Report Scope:
| Report Attributes | Report Details |
|---|---|
| Report Title | Non-invasive Prenatal Testing (NIPT) Market Research Report |
| By Products | Consumables, Reagent, Ultrasound, NGS, PCR, Microarray |
| By Applications | Aneuploidy, Microdeletion |
| By Key Players | Next Biosciences (Pty) Limited, Illumina Inc., Myriad Genetics Inc., Natera Inc., Laboratory Corporation of America Holdings (LabCorp), Beijing Genomics Institute, Quest Diagnostics, F. Hoffmann-La Roche, LifeCodexx AG, Yourgene Health Plc, PerkinElmer Inc., NIPD Genetics |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 114 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
The study includes a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the non-invasive prenatal testing (nipt) market. Furthermore, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by products, applications, and region. Additionally, the report also covers the exhaustive regulatory landscape, technology landscape, value chain analysis and PEST analysis.
Request Free Sample
Request Free Sample
Non-invasive Prenatal Testing (NIPT) Market COVID-19 Impact Analysis
The epidemic of COVID-19 has caused significant economic and social upheaval. The pandemic has had an influence on the supply chain and value chain of numerous businesses. The non-invasive prenatal testing (nipt) market is not an exception. The impact of the COVID-19 pandemic will be analyzed on the basis of the overall industry including both the demand side and supply side perspectives. The effects of the pandemic would be studied and analyzed for short-term and long-term scenarios. This would assist to formulate business strategies for the period during the pandemic as well as the post-pandemic period for all stakeholders involved in the industry including suppliers, manufacturers, vendors, distributors, and end-users.
Non-invasive Prenatal Testing (NIPT) Market Key Segment Analysis
The report study delivers a critical assessment on the non-invasive prenatal testing (nipt) by segmenting the total addressable market based on products, applications, and region. All the segments & categories of the non-invasive prenatal testing (nipt) market are evaluated on the basis of past and future trends. The data for the market and its segments & categories are provided from 2016 to 2028. The report has identified the important segments & categories offering the most to the total addressable market growth in terms of revenue as well as the factors advancing their development.
The report includes a detailed segment analysis of the non-invasive prenatal testing (nipt) market based on products, applications, and region. On the basis of Products, the market can be classified into Consumables, Reagent, Ultrasound, NGS, PCR, Microarray. Based on the Applications, the market can be segmented into the Aneuploidy, Microdeletion.
Key Market Players & Competitive Landscape of Non-invasive Prenatal Testing (NIPT) Market
The report provides exhaustive information on all the key players in the industry based on company overview, company market share, recent developments, business strategies, and financial performance among others. The report will also provide an extensive product portfolio for each company along with detailed descriptions/features. This report also contains useful recommendations for both established and new players around the world.
Some of the key players in the non-invasive prenatal testing (nipt) market include:
- Next Biosciences (Pty) Limited
- Illumina Inc.
- Myriad Genetics Inc.
- Natera Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Beijing Genomics Institute
- Quest Diagnostics
- F. Hoffmann-La Roche
- LifeCodexx AG
- Yourgene Health Plc
- PerkinElmer Inc.
- NIPD Genetics
Due to the existence of multiple significant competitors, the industry is very competitive. Several inorganic growth techniques, such as acquisitions, mergers, and regional expansion are being pursued by the majority of manufacturers in order to increase their market share and obtain a competitive edge.
Key Benefits of the Report:
- COVID-19 Impact Analysis (A completely separate Chapter)
- Market size in terms of revenue from 2016 to 2028
- Market size for each segment from 2016 to 2028, by Region
- Market Attractiveness Analysis for all the segments
- Market Drivers, Restraints, and Opportunities
- Regional Market Trends
- Value Chain Analysis
- Regulatory Landscape
- Technology Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Competitive Landscape and Company Market Shares
Non-invasive Prenatal Testing (NIPT) Market Regional Analysis
The report provides market size for all the segments and their categories for regions that include North America, Europe, Asia Pacific (APAC), Latin America and the Middle East & Africa (MEA). These regions are further bifurcated into major countries including the U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others. The report has analyzed both developed & developing regions considered for research of the non-invasive prenatal testing (nipt) market. To assist firms in developing effective development strategies, the regional analysis section provides a complete overview of the industry from a number of countries and regions.
Request Free SampleINQUIRY_TEXT
Significant aspects of the Non-invasive Prenatal Testing (NIPT) Market Report:
- Drivers, Restraints, Opportunities and Recent Trends of the non-invasive prenatal testing (nipt) market
- Structure of the market and projections for the next few years
- Market situation for each segment and region
- By Products
- Consumables
- Reagent
- Ultrasound
- NGS
- PCR
- Microarray
- By Applications
- Aneuploidy
- Microdeletion
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East & Africa
- An evaluation of upstream raw materials, downstream demand, and existing market dynamics is carried out
- Company Market Shares, Competitive Landscape, SWOT Analysis, and Product Specification
The findings would be further affirmed and expanded upon through primary research conducted with industry professionals and decision-makers from around the world. A wide range of data validation and market estimation approaches were used to further assemble and validate the results gathered during the research. We also have our data forecasting algorithm that projects market growth over the year 2028. We performed both primary and secondary research to gain a clear overview of the non-invasive prenatal testing (nipt) market. This helped us understand existing market dynamics like supply-demand imbalance, pricing trends, product preferences, consumer behavior, and other factors.
The following are the justifications for purchasing the Non-invasive Prenatal Testing (NIPT) Market report:
- Learn how to gather and analyze strategically essential competitor data and resources to develop effective R&D strategies.
- Consider the target demography when classifying possible new clients or partners.
- Identify the strategic priorities of top firms to establish tactical efforts.
- Selecting Leading Manufacturers might help you determine mergers and acquisitions more effectively.
- The study provides an in-depth analysis of market segments, sub-segments, and the regional prognosis for the market in consideration.
- The report provides an in-depth overview of the supplier analysis, competitive landscape, and major industry strategies that will help businesses obtain a competitive advantage in the industry.
Frequently Asked Questions
- Next Biosciences (Pty) Limited
- Illumina Inc.
- Myriad Genetics Inc.
- Natera Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Beijing Genomics Institute
- Quest Diagnostics
- F. Hoffmann-La Roche
- LifeCodexx AG
- Yourgene Health Plc
- PerkinElmer Inc.
- NIPD Genetics
Table Of Content
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Non-invasive Prenatal Testing (NIPT) Market Share by Type (2020-2026) 1.5.2 Consumables 1.5.3 Reagent 1.5.4 Ultrasound 1.5.5 NGS 1.5.6 PCR 1.5.7 Microarray 1.6 Market by Application 1.6.1 Global Non-invasive Prenatal Testing (NIPT) Market Share by Application (2020-2026) 1.6.2 Aneuploidy 1.6.3 Microdeletion 1.7 Non-invasive Prenatal Testing (NIPT) Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Non-invasive Prenatal Testing (NIPT) Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Non-invasive Prenatal Testing (NIPT) Market 3.1 Value Chain Status 3.2 Non-invasive Prenatal Testing (NIPT) Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Non-invasive Prenatal Testing (NIPT) 3.2.3 Labor Cost of Non-invasive Prenatal Testing (NIPT) 3.2.3.1 Labor Cost of Non-invasive Prenatal Testing (NIPT) Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 Next Biosciences (Pty) Limited 4.1.1 Next Biosciences (Pty) Limited Basic Information 4.1.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.1.3 Next Biosciences (Pty) Limited Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.1.4 Next Biosciences (Pty) Limited Business Overview 4.2 Illumina Inc. 4.2.1 Illumina Inc. Basic Information 4.2.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.2.3 Illumina Inc. Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.2.4 Illumina Inc. Business Overview 4.3 Myriad Genetics Inc. 4.3.1 Myriad Genetics Inc. Basic Information 4.3.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.3.3 Myriad Genetics Inc. Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.3.4 Myriad Genetics Inc. Business Overview 4.4 Natera Inc. 4.4.1 Natera Inc. Basic Information 4.4.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.4.3 Natera Inc. Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.4.4 Natera Inc. Business Overview 4.5 Laboratory Corporation of America Holdings (LabCorp) 4.5.1 Laboratory Corporation of America Holdings (LabCorp) Basic Information 4.5.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.5.3 Laboratory Corporation of America Holdings (LabCorp) Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.5.4 Laboratory Corporation of America Holdings (LabCorp) Business Overview 4.6 Beijing Genomics Institute 4.6.1 Beijing Genomics Institute Basic Information 4.6.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.6.3 Beijing Genomics Institute Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.6.4 Beijing Genomics Institute Business Overview 4.7 Quest Diagnostics 4.7.1 Quest Diagnostics Basic Information 4.7.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.7.3 Quest Diagnostics Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.7.4 Quest Diagnostics Business Overview 4.8 F. Hoffmann-La Roche 4.8.1 F. Hoffmann-La Roche Basic Information 4.8.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.8.3 F. Hoffmann-La Roche Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.8.4 F. Hoffmann-La Roche Business Overview 4.9 LifeCodexx AG 4.9.1 LifeCodexx AG Basic Information 4.9.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.9.3 LifeCodexx AG Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.9.4 LifeCodexx AG Business Overview 4.10 Yourgene Health Plc 4.10.1 Yourgene Health Plc Basic Information 4.10.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.10.3 Yourgene Health Plc Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.10.4 Yourgene Health Plc Business Overview 4.11 PerkinElmer Inc. 4.11.1 PerkinElmer Inc. Basic Information 4.11.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.11.3 PerkinElmer Inc. Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.11.4 PerkinElmer Inc. Business Overview 4.12 NIPD Genetics 4.12.1 NIPD Genetics Basic Information 4.12.2 Non-invasive Prenatal Testing (NIPT) Product Profiles, Application and Specification 4.12.3 NIPD Genetics Non-invasive Prenatal Testing (NIPT) Market Performance (2015-2020) 4.12.4 NIPD Genetics Business Overview 5 Global Non-invasive Prenatal Testing (NIPT) Market Analysis by Regions 5.1 Global Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Regions 5.1.1 Global Non-invasive Prenatal Testing (NIPT) Sales by Regions (2015-2020) 5.1.2 Global Non-invasive Prenatal Testing (NIPT) Revenue by Regions (2015-2020) 5.2 North America Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 5.3 Europe Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 5.6 South America Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 6 North America Non-invasive Prenatal Testing (NIPT) Market Analysis by Countries 6.1 North America Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Countries 6.1.1 North America Non-invasive Prenatal Testing (NIPT) Sales by Countries (2015-2020) 6.1.2 North America Non-invasive Prenatal Testing (NIPT) Revenue by Countries (2015-2020) 6.1.3 North America Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 6.2 United States Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 6.2.1 United States Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 6.3 Canada Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 6.4 Mexico Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7 Europe Non-invasive Prenatal Testing (NIPT) Market Analysis by Countries 7.1 Europe Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Countries 7.1.1 Europe Non-invasive Prenatal Testing (NIPT) Sales by Countries (2015-2020) 7.1.2 Europe Non-invasive Prenatal Testing (NIPT) Revenue by Countries (2015-2020) 7.1.3 Europe Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.2 Germany Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.2.1 Germany Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.3 UK Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.3.1 UK Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.4 France Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.4.1 France Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.5 Italy Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.5.1 Italy Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.6 Spain Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.6.1 Spain Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 7.7 Russia Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 7.7.1 Russia Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Market Analysis by Countries 8.1 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8.2 China Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.2.1 China Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8.3 Japan Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.3.1 Japan Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8.4 South Korea Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.4.1 South Korea Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8.5 Australia Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.6 India Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.6.1 India Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 8.7 Southeast Asia Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 9 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Market Analysis by Countries 9.1 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 9.2 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 9.3 UAE Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 9.4 Egypt Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 9.5 Nigeria Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 9.6 South Africa Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 10 South America Non-invasive Prenatal Testing (NIPT) Market Analysis by Countries 10.1 South America Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Countries 10.1.1 South America Non-invasive Prenatal Testing (NIPT) Sales by Countries (2015-2020) 10.1.2 South America Non-invasive Prenatal Testing (NIPT) Revenue by Countries (2015-2020) 10.1.3 South America Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 10.2 Brazil Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 10.2.1 Brazil Non-invasive Prenatal Testing (NIPT) Market Under COVID-19 10.3 Argentina Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 10.4 Columbia Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 10.5 Chile Non-invasive Prenatal Testing (NIPT) Sales and Growth Rate (2015-2020) 11 Global Non-invasive Prenatal Testing (NIPT) Market Segment by Types 11.1 Global Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Non-invasive Prenatal Testing (NIPT) Sales and Market Share by Types (2015-2020) 11.1.2 Global Non-invasive Prenatal Testing (NIPT) Revenue and Market Share by Types (2015-2020) 11.2 Consumables Sales and Price (2015-2020) 11.3 Reagent Sales and Price (2015-2020) 11.4 Ultrasound Sales and Price (2015-2020) 11.5 NGS Sales and Price (2015-2020) 11.6 PCR Sales and Price (2015-2020) 11.7 Microarray Sales and Price (2015-2020) 12 Global Non-invasive Prenatal Testing (NIPT) Market Segment by Applications 12.1 Global Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Non-invasive Prenatal Testing (NIPT) Sales and Market Share by Applications (2015-2020) 12.1.2 Global Non-invasive Prenatal Testing (NIPT) Revenue and Market Share by Applications (2015-2020) 12.2 Aneuploidy Sales, Revenue and Growth Rate (2015-2020) 12.3 Microdeletion Sales, Revenue and Growth Rate (2015-2020) 13 Non-invasive Prenatal Testing (NIPT) Market Forecast by Regions (2020-2026) 13.1 Global Non-invasive Prenatal Testing (NIPT) Sales, Revenue and Growth Rate (2020-2026) 13.2 Non-invasive Prenatal Testing (NIPT) Market Forecast by Regions (2020-2026) 13.2.1 North America Non-invasive Prenatal Testing (NIPT) Market Forecast (2020-2026) 13.2.2 Europe Non-invasive Prenatal Testing (NIPT) Market Forecast (2020-2026) 13.2.3 Asia-Pacific Non-invasive Prenatal Testing (NIPT) Market Forecast (2020-2026) 13.2.4 Middle East and Africa Non-invasive Prenatal Testing (NIPT) Market Forecast (2020-2026) 13.2.5 South America Non-invasive Prenatal Testing (NIPT) Market Forecast (2020-2026) 13.3 Non-invasive Prenatal Testing (NIPT) Market Forecast by Types (2020-2026) 13.4 Non-invasive Prenatal Testing (NIPT) Market Forecast by Applications (2020-2026) 13.5 Non-invasive Prenatal Testing (NIPT) Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Inquiry For Buying
Non-invasive Prenatal Testing (NIPT)
Request Sample
Non-invasive Prenatal Testing (NIPT)
